Mage Biotechnologies

Mage Biotechnologies is a holding company active in the fields of longevity and regenerative medicine. Our core areas of expertise are in stem-cell-based and exosome-based technologies. We undertake our business activities through several subsidiaries: Lipocube https://www.linkedin.com/company/lipocube-biotechnology/ https://lipocube.com/ Lipocube specializes in the development of advanced medical devices that enable the extraction and processing of autologous adipose-based stem cells. Recure https://www.linkedin.com/company/recure-cosmetics/ https://morphiya.com/ Recure develops, produces and markets cosmetics, supplements, and injectables featuring our proprietary Hybrid Exosomes (HybrosomesTM) technology that promote tissue regeneration and rejuvenation. London Regenerative Institute https://www.linkedin.com/company/london-regenerative-institute/ https://london-regenerative.com/ LRI provides diagnostics, treatments, and clinical services that help individuals live healthier and...

Mage biotechnologies operates in the Biotechnology industry.

Mage biotechnologies's revenue is 11m - 100m

Mage biotechnologies has 11 - 50 employees.